Literature DB >> 4571325

Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli.

N F Pierce.   

Abstract

Natural cholera toxoid appears to act as a competitive inhibitor of cholera enterotoxin and is thus a useful tool for studying the interaction of cholera enterotoxin with cell membranes. Cholera enterotoxin binds to gut mucosa more rapidly than does its natural toxoid. Once binding occurs, however, it appears to be prolonged for both materials. Formalinized cholera toxoid has no inhibitory effect upon cholera enterotoxin. Enterotoxic activity, ability to bind to gut mucosa, and antitoxigenicity appear to be independent properties of cholera enterotoxin. Natural cholera toxoid does not inhibit Escherichia coli enterotoxin, indicating that although the two enterotoxins activate the same mucosal secretory mechanism they occupy different binding sites in the mucosa. Ganglioside, which may be the mucosal receptor of cholera enterotoxin, is highly efficient in deactivating cholera enterotoxin. By contrast, ganglioside is relatively inefficient in deactivating heat-labile E. coli enterotoxin and is without effect upon the heat-stable component of E. coli enterotoxin. These findings suggest that ganglioside is not likely to be the mucosal receptor for E. coli enterotoxin. Differences in cellular binding of E. coli and cholera enterotoxins may explain, at least in part, the marked differences in the time of onset and duration of their effects upon gut secretion.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4571325      PMCID: PMC2139228          DOI: 10.1084/jem.137.4.1009

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Stimulation of glycerol production in fat cells by cholera toxin.

Authors:  M Vaughan; N F Pierce; W B Greenough
Journal:  Nature       Date:  1970-05-16       Impact factor: 49.962

2.  Response of the rabbit ileal loop to cell-free products from Escherichia coli enteropathogenic for swine.

Authors:  H W Moon; S C Whipp; G W Engstrom; A L Baetz
Journal:  J Infect Dis       Date:  1970-02       Impact factor: 5.226

3.  Studies on Escherichia coli enterotoxin.

Authors:  H W Smith; S Halls
Journal:  J Pathol Bacteriol       Date:  1967-04

4.  A heat-labile enterotoxin from strains of Eschericha coli enteropathogenic for pigs.

Authors:  C L Gyles; D A Barnum
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

5.  Reversal of cholera exotoxin-induced jejunal secretion by cycloheximide.

Authors:  D T Harper; J H Yardley; T R Hendrix
Journal:  Johns Hopkins Med J       Date:  1970-05

6.  Inhibition of cholera toxin action in the rabbit by cycloheximide.

Authors:  H A Serebro; F L Iber; J H Yardley; T R Hendrix
Journal:  Gastroenterology       Date:  1969-03       Impact factor: 22.682

7.  Antitoxic immunity in experimental canine cholera.

Authors:  G T Curlin; A Subong; J P Craig; C C Carpenter
Journal:  Trans Assoc Am Physicians       Date:  1968

8.  Response of canine Thiry-Vella jejunal loops to cholera exotoxin and its modification by ethacrynic acid.

Authors:  C C Carpenter; G T Curlin; W B Greenough
Journal:  J Infect Dis       Date:  1969-09       Impact factor: 5.226

9.  Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora.

Authors:  S L Gorbach; J G Banwell; B D Chatterjee; B Jacobs; R B Sack
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  35 in total

1.  Short communications. Subunit A from cholera toxin is an activator of adenylate cyclase in pigeon erythrocytes.

Authors:  S Van Heyningen; C A King
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

2.  Characterization of an anti-idiotypic MoAb bearing an internal image of the receptor-binding epitope of cholera toxin.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  Mobility of cholera toxin receptors on rat lymphocyte membranes.

Authors:  S W Craig; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

4.  Mechanism of action of cholera toxin and the mobile receptor theory of hormone receptor-adenylate cyclase interactions.

Authors:  V Bennett; E O'Keefe; P Cuatrecasaş
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

5.  Increased adhesion of Chinese hamster ovary cells to substratum by cholera enterotoxin.

Authors:  R Nozawa; F Kon; T Yokota; M Ohashi; S Kuwahara
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin. Relations to the mode of activation by hormones.

Authors:  V Bennett; L Mong; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-11-07       Impact factor: 1.843

7.  Morphological and steroidogenic changes in cultured adrenal tumor cells induced by a subunit of cholera enterotoxin.

Authors:  S T Donta; S R Kreiter; G Wendelschafer-Crabb
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

8.  Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli.

Authors:  S L Kunkel; D C Robertson
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

9.  Reduction of reactivity of Escherichia coli enterotoxins by intestinal mucosal components.

Authors:  H D Cole; T E Staley; S C Whipp
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Mechanism of action of Vibrio cholerae enterotoxin. Effects on adenylate cyclase of toad and rat erythrocyte plasma membranes.

Authors:  V Bennett; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-06-03       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.